Carlos López Otín

Dr. Otín is Professor of Biochemistry at the University of Oviedo where he has been leading research in oncology and aging over the past decades. His successful scientific career has led to the discovery of more than sixty human genes unraveling their role in health and disease.

He was part of the first human genome sequencing project and since 2010 he leads the Spanish branch of the international consortium of Cancer Genomes, organization that has identified the mutated oncogenes of hundreds on cancer patients. Carlos latest research includes de discovery of two novel syndromes involved in accelerated aging, the discovery of new genes related with sudden death and hereditary melanoma. Moreover, he has focused several projects on longevity and healthy aging, including the use of specific bacteria that promotes longevity.

Carlos is a member of the European Academy of Science and the Royal Spanish Academy of Science, as well as Honorary Doctor by several international Unviersities. He received numerous awards like Chemistry award by FEBS and the Research National Award “Santiago Ramón y Cajal”. Carlos joined the Scientific Advisory Board of Microviable Therapeutics in 2021 to advance scientific evidence of microbiota-based biotherapeutic products specially focused on longevity and aging.